Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “C-Difficile”

132 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 132 results

Testing effectiveness (Phase 2)Looking for participantsNCT07285213
What this trial is testing

Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody

Who this might be right for
Clostridioides Difficile Infection
AstraZeneca 230
Early research (Phase 1)Study completedNCT01704937
What this trial is testing

Fecal Microbiota Transplant (FMT) for Relapsing C. Difficile Infection in Adults and Children Using a Frozen Inoculum

Who this might be right for
Clostridium Difficile Infection
Massachusetts General Hospital 20
Post-approval studies (Phase 4)WithdrawnNCT01552668
What this trial is testing

Fidaxomicin to Prevent Clostridium Difficile Colonization

Who this might be right for
Clostridium Difficile Infection
Washington University School of Medicine
Large-scale testing (Phase 3)Ended earlyNCT05153499
What this trial is testing

A Trial of CP101 for the Prevention of Recurrent CDI (PRISM4)

Who this might be right for
Recurrent C. Difficile Infection
Finch Research and Development LLC. 19
Testing effectiveness (Phase 2)Study completedNCT03110133
What this trial is testing

Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff

Who this might be right for
Clostridium Difficile Infection Recurrence
Finch Research and Development LLC. 206
Large-scale testing (Phase 3)Ended earlyNCT03005379
What this trial is testing

Microbiota or Placebo After Antimicrobial Therapy for Recurrent C. Difficile at Home (MATCH)

Who this might be right for
Clostridium Difficile Infection
VA Office of Research and Development 153
Large-scale testing (Phase 3)Study completedNCT05831189
What this trial is testing

A Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile Infection

Who this might be right for
Clostridium Difficile Infection Recurrence
Ferring Pharmaceuticals 41
Not applicableUnknownNCT03586206
What this trial is testing

Relationship Between C. Difficile Toxins' Serum Level With C. Difficile Infection

Who this might be right for
Clostridium DifficileClostridium Difficile Infection
Roma Tre University 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT05805826
What this trial is testing

To Understand the Safety and Effects of a C. Difficile Vaccine With New Adds-Ons That Will Be Given to Healthy Adults

Who this might be right for
Clostridoides Difficile Associated Disease
Pfizer 936
Not applicableActive Not RecruitingNCT05800704
What this trial is testing

Support of Colonization Resistance of the Gut Microbiota with the Synbiotic Food Supplement Nagasin®

Who this might be right for
C. Difficile Enteritis
University of Zurich 49
Post-approval studies (Phase 4)Ended earlyNCT00177970
What this trial is testing

IVIG Versus Placebo for the Treatment of Patients With Severe C-Diff

Who this might be right for
Clostridium Difficile-associated Diarrhea (CDAD)
University of Pittsburgh 14
Large-scale testing (Phase 3)Study completedNCT03931941
What this trial is testing

Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCH CD3-OLS)

Who this might be right for
Clostridium Difficile InfectionInfectionCommunicable Diseases
Rebiotix Inc. 793
Not applicableStudy completedNCT02747017
What this trial is testing

Observational Study of C. Diff in Post-Transplant Patients

Who this might be right for
Clostridium Difficile
University of Minnesota 132
Testing effectiveness (Phase 2)Study completedNCT00034294
What this trial is testing

GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated Diarrhea

Who this might be right for
Clostridium Difficile-Associated DiarrheaClostridium EnterocolitisClostridium Difficile Diarrhea+2 more
Genzyme, a Sanofi Company 300
Not applicableLooking for participantsNCT05389904
What this trial is testing

Pre-emptive Prevention for Patients at High Risk for Hospital-onset Clostridioides Difficile

Who this might be right for
C. Difficile
Brigham and Women's Hospital 300
Large-scale testing (Phase 3)Study completedNCT00196794
What this trial is testing

GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C. Difficile-Associated Diarrhea

Who this might be right for
Clostridium EnterocolitisDiarrhea
Genzyme, a Sanofi Company 520
Not applicableEnded earlyNCT02730325
What this trial is testing

To Evaluate the Impact of SBI on C. Difficile in Hospitalized UC Patients

Who this might be right for
Clostridium Difficile
Northwestern University 10
Not applicableStudy completedNCT06669936
What this trial is testing

Rescue FMT with Bezlotoxumab for Recurrent C. Difficile Infection

Who this might be right for
Recurrent C. Difficile Infection
Alexander Khoruts 24
Large-scale testing (Phase 3)Ended earlyNCT03796650
What this trial is testing

Fecal Transplantation for Primary Clostridium Difficile Infection

Who this might be right for
Clostridium Difficile Infection
Oslo University Hospital 104
Post-approval studies (Phase 4)WithdrawnNCT04241744
What this trial is testing

Prospective Trial of Oral Vancomycin Therapy vs. Placebo for Prevention of CDI

Who this might be right for
CDI
Creighton University
Next Page